Answer
Yes. The subcutaneous formulation may be used by a patient or caregiver after initial intravenous treatment, appropriate training and approval from the specialist.
Sources for this answer
- Entyvio 108 mg solution for injection in pre-filled syringe — Current selected SmPCemc · Summary of Product Characteristics
- NHSNHS · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.